These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3934648

  • 41. Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats.
    Karasawa A, Guo JP, Ma XL, Lefer AM.
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):95-105. PubMed ID: 1719297
    [Abstract] [Full Text] [Related]

  • 42. Arachidonic acid in splanchnic artery occlusion shock.
    Bridenbaugh GA, Flynn JT, Lefer AM.
    Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849
    [Abstract] [Full Text] [Related]

  • 43. Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia.
    Brackett DJ, Schaefer CF, Lerner MR, Holaday JW, Fagraeus L, Wilson MF.
    Regul Pept; 1990 Jul 30; 29(2-3):153-62. PubMed ID: 2120745
    [Abstract] [Full Text] [Related]

  • 44. Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat.
    Sturniolo R, Squadrito F, Campo GM, Vinci R, Calatroni A, Prosdocimi M, Caputi AP.
    J Cardiovasc Pharmacol; 1991 Feb 30; 17(2):261-6. PubMed ID: 1709231
    [Abstract] [Full Text] [Related]

  • 45. Afferent vagal fibres and central cholinergic mechanisms are involved in the TRH-induced reversal of haemorrhagic shock.
    Vergoni AV, Marrama D, Guarini S, Tagliavini S, Bazzani C, Maugeri A, Bertolini A.
    Pharmacol Res; 1991 Apr 30; 23(3):271-8. PubMed ID: 1906171
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. A pharmacological study of the cardiovascular effects of TRH-T in haemorrhagic shock in rats.
    Guarini S, Gherardi S, Calabrò G, Bertolini A.
    Arch Int Pharmacodyn Ther; 1989 Apr 30; 299():65-76. PubMed ID: 2505701
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
    Stahl GL, Bitterman H, Terashita Z, Lefer AM.
    Eur J Pharmacol; 1988 May 10; 149(3):233-40. PubMed ID: 3409951
    [Abstract] [Full Text] [Related]

  • 55. Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock.
    Zingarelli B, Squadrito F, Ioculano M, Altavilla D, Bussolino F, Campo GM, Caputi AP.
    Eur J Pharmacol; 1992 Nov 03; 222(1):13-9. PubMed ID: 1468489
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Cardiorespiratory alterations produced by centrally administered thyrotropin-releasing hormone during canine endotoxin shock.
    Leffew SD, Williams CD, Janssen HF.
    Circ Shock; 1987 Nov 03; 21(3):225-32. PubMed ID: 3105908
    [Abstract] [Full Text] [Related]

  • 59. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
    Furlan LE, Johnson G, Siegfried M, Lefer AM.
    J Pharmacol Exp Ther; 1990 May 03; 253(2):525-9. PubMed ID: 2140129
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.